BioCorRx (BICX) Cost of Revenue (2010 - 2026)

BioCorRx (BICX) posted Cost of Revenue of $25184.0 for Q1 2026, up 1410.74% sequentially from $1667.0 in Q1 2024.

BioCorRx (BICX) Cost of Revenue (2010 - 2026) Analysis & Trends

BioCorRx has reported Cost of Revenue for 16 years, with the latest figure at $25184.0 in Q1 2026.

Quarterly Cost of Revenue changed N/A year-over-year to $25184.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25184.0 (changed N/A YoY) and the FY2024 annual result came in at $1667.0, down 95.37% from the prior year.
Cost of Revenue rose to $25184.0 in Q1 2026 per BICX's latest filing, from $1667.0 in the prior quarter.
Over five years, Cost of Revenue peaked at $25184.0 in Q1 2026 and troughed at $1535.0 in Q1 2022.
A 4-year average of $7811.6 and a median of $6278.5 in 2022 frame the typical range for Cost of Revenue.
The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 465.21% in 2023, then sank 80.79% in 2024.
Over 4 years, Cost of Revenue stood at $8676.0 in 2022, then soared by 50.45% to $13053.0 in 2023, then slumped by 87.23% to $1667.0 in 2024, then soared by 1410.74% to $25184.0 in 2026.
According to Business Quant data, Cost of Revenue over the past three periods registered $25184.0, $1667.0, and $13053.0 for Q1 2026, Q1 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	5.04 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	1.17 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	254.90 Mn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	2.39 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	1.13 Bn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	1.35 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	1.09 Bn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	451.78 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	413.93 Mn
10	BioCorRx	1.49 Mn	1.47 Mn	-	-

Download Data